These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 28461158)
1. Pancreatic stellate cells increase pancreatic cancer cells invasion through the hepatocyte growth factor /c-Met/survivin regulated by P53/P21. Yang XP; Liu SL; Xu JF; Cao SG; Li Y; Zhou YB Exp Cell Res; 2017 Aug; 357(1):79-87. PubMed ID: 28461158 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic Stellate Cells Facilitate Perineural Invasion of Pancreatic Cancer via HGF/c-Met Pathway. Nan L; Qin T; Xiao Y; Qian W; Li J; Wang Z; Ma J; Ma Q; Wu Z Cell Transplant; 2019; 28(9-10):1289-1298. PubMed ID: 31161784 [TBL] [Abstract][Full Text] [Related]
3. Paracrine HGF/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP/HIF-1α. Yan B; Jiang Z; Cheng L; Chen K; Zhou C; Sun L; Qian W; Li J; Cao J; Xu Q; Ma Q; Lei J Exp Cell Res; 2018 Oct; 371(1):63-71. PubMed ID: 30056064 [TBL] [Abstract][Full Text] [Related]
4. The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic cancer. Patel MB; Pothula SP; Xu Z; Lee AK; Goldstein D; Pirola RC; Apte MV; Wilson JS Carcinogenesis; 2014 Aug; 35(8):1891-900. PubMed ID: 24876152 [TBL] [Abstract][Full Text] [Related]
5. Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53. Liu WT; Jing YY; Yu GF; Chen H; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX Cell Cycle; 2016; 15(7):886-94. PubMed ID: 27077227 [TBL] [Abstract][Full Text] [Related]
6. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro. Xu J; Liu S; Yang X; Cao S; Zhou Y Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386 [TBL] [Abstract][Full Text] [Related]
8. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells. Qian LW; Mizumoto K; Inadome N; Nagai E; Sato N; Matsumoto K; Nakamura T; Tanaka M Int J Cancer; 2003 May; 104(5):542-9. PubMed ID: 12594808 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Matsushita A; Götze T; Korc M Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973 [TBL] [Abstract][Full Text] [Related]
10. Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway. Ide T; Kitajima Y; Miyoshi A; Ohtsuka T; Mitsuno M; Ohtaka K; Koga Y; Miyazaki K Int J Cancer; 2006 Dec; 119(12):2750-9. PubMed ID: 16998831 [TBL] [Abstract][Full Text] [Related]
11. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion. Cao HH; Cheng CY; Su T; Fu XQ; Guo H; Li T; Tse AK; Kwan HY; Yu H; Yu ZL Mol Cancer; 2015 May; 14():103. PubMed ID: 25971889 [TBL] [Abstract][Full Text] [Related]
12. Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells. Bauer TW; Somcio RJ; Fan F; Liu W; Johnson M; Lesslie DP; Evans DB; Gallick GE; Ellis LM Mol Cancer Ther; 2006 Jul; 5(7):1676-82. PubMed ID: 16891453 [TBL] [Abstract][Full Text] [Related]
13. Correlation between hypoxia and HGF/c-MET expression in the management of pancreatic cancer. Sharma R; Malviya R Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188869. PubMed ID: 36842767 [TBL] [Abstract][Full Text] [Related]
14. Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF). Carpenter BL; Chen M; Knifley T; Davis KA; Harrison SMW; Stewart RL; O'Connor KL J Biol Chem; 2015 Nov; 290(45):27228-27238. PubMed ID: 26381405 [TBL] [Abstract][Full Text] [Related]
16. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945 [TBL] [Abstract][Full Text] [Related]
17. MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk. Modica C; Tortarolo D; Comoglio PM; Basilico C; Vigna E Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544501 [TBL] [Abstract][Full Text] [Related]
18. Human bone marrow-derived stem cell proliferation is inhibited by hepatocyte growth factor via increasing the cell cycle inhibitors p53, p21 and p27. Chen K; Perez-Stable C; D'Ippolito G; Schiller PC; Roos BA; Howard GA Bone; 2011 Dec; 49(6):1194-204. PubMed ID: 21907315 [TBL] [Abstract][Full Text] [Related]
19. [Effect of transferred NK4 gene on biological characteristics of human pancreatic cancer cell line SW1990]. Lai RX; Yuan SZ; Nakamura T Ai Zheng; 2004 Oct; 23(10):1134-8. PubMed ID: 15473922 [TBL] [Abstract][Full Text] [Related]
20. Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis. Xu Z; Pang TCY; Liu AC; Pothula SP; Mekapogu AR; Perera CJ; Murakami T; Goldstein D; Pirola RC; Wilson JS; Apte MV Br J Cancer; 2020 May; 122(10):1486-1495. PubMed ID: 32203220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]